This is the authors' abstract. We don't add key points for this paper.
We demonstrate label-free imaging of cerebral β-amyloidosis ex vivo and in a living mouse model of Alzheimer's disease using extended-focus Fourier domain optical coherence microscopy (xfOCM). xfOCM provides 3D, high-resolution images of individual β-amyloid plaques in the brain parenchyma and vasculature and requires no staining of the alzheimeric sample under investigation. xfOCM also opens the possibility to perform minimally invasive studies of β-amyloid pathology in vivo, without the use of labeling methods, which potentially confound experimental findings.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bolmont et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: